GLP1R and Other metabolic disease: Amid this treatment landscape, glucagon-like peptide-1 receptor (GLP-1R) agonists already established as therapies for metabolic disorders have emerged as potential candidates for addiction treatment, with recent research suggesting they may reduce alcohol consumption in preclinical and clinical studies.